SALL3, spalt like transcription factor 3, 27164

N. diseases: 24; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0238198
Disease: Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors
0.300 Biomarker group CTD_human Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. 27793025 2016
CUI: C3179349
Disease: Gastrointestinal Stromal Sarcoma
Gastrointestinal Stromal Sarcoma
0.300 Biomarker disease CTD_human Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. 27793025 2016
CUI: C0006413
Disease: Burkitt Lymphoma
Burkitt Lymphoma
0.300 Biomarker disease CTD_human The genetic landscape of mutations in Burkitt lymphoma. 23143597 2012
CUI: C0343640
Disease: African Burkitt's lymphoma
African Burkitt's lymphoma
0.300 Biomarker disease CTD_human The genetic landscape of mutations in Burkitt lymphoma. 23143597 2012
CUI: C4721444
Disease: Burkitt Leukemia
Burkitt Leukemia
0.300 Biomarker disease CTD_human The genetic landscape of mutations in Burkitt lymphoma. 23143597 2012
CUI: C0376634
Disease: Craniofacial Abnormalities
Craniofacial Abnormalities
0.300 Biomarker group CTD_human Loss of the Sall3 gene leads to palate deficiency, abnormalities in cranial nerves, and perinatal lethality. 15282310 2004
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.300 GeneticVariation disease UNIPROT
CUI: C1305855
Disease: Body mass index
Body mass index
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C1305855
Disease: Body mass index
Body mass index
0.100 GeneticVariation phenotype GWASCAT Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. 30239722 2019
CUI: C0596887
Disease: mathematical ability
mathematical ability
0.100 GeneticVariation phenotype GWASCAT Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 30038396 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 GeneticVariation group BEFREE We identified 92 CpG islands significantly hypermethylated in thymic carcinoma in relation to thymoma and selected G protein subunit gamma 4 (GNG4), growth hormone secretagogue receptor (GHSR), homeobox D9 (HOXD9) and spalt like transcription factor 3 (SALL3), which are related to cancer. 31746370 2020
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 GeneticVariation group BEFREE We identified 92 CpG islands significantly hypermethylated in thymic carcinoma in relation to thymoma and selected G protein subunit gamma 4 (GNG4), growth hormone secretagogue receptor (GHSR), homeobox D9 (HOXD9) and spalt like transcription factor 3 (SALL3), which are related to cancer. 31746370 2020
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 AlteredExpression disease BEFREE These results indicated that promoter CpG island hypermethylation contributes to the downregulation of sall3 mRNA transcription in HCC. 22690083 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 PosttranslationalModification group BEFREE This functional characterization of SALL3 sheds light on regulatory mechanisms for DNMT3A and provides new strategies to inhibit aberrant methylation in cancer. 19139273 2009
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 PosttranslationalModification group BEFREE This functional characterization of SALL3 sheds light on regulatory mechanisms for DNMT3A and provides new strategies to inhibit aberrant methylation in cancer. 19139273 2009
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 Biomarker disease BEFREE We also show that SALL3 is inducible by BMP-4 and silenced by associated DNA methylation in hepatocellular carcinoma (HCC). 19139273 2009
CUI: C0040100
Disease: Thymoma
Thymoma
0.010 Biomarker disease BEFREE No significant differences were observed in the promoter methylation of GNG4, HOXD9, or SALL3 between thymoma and the thymus. 31746370 2020
CUI: C0205969
Disease: Thymic Carcinoma
Thymic Carcinoma
0.010 PosttranslationalModification disease BEFREE DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma. 31746370 2020
Congenital contractural arachnodactyly
0.010 Biomarker disease BEFREE The results obtained in the current study suggested that spalt like transcription factor 3 and OPCML intronic transcript 1 may serve an important role in the development and progression of CCA. 31612038 2019
CUI: C0008487
Disease: Chordoma
Chordoma
0.010 Biomarker disease BEFREE Immunohistochemistry revealed LMX1A to be dominant in skull base chordoma, SALL3 to be unique to spine chordoma, and T to be common to both chordoma subtypes. 28844110 2018
CUI: C0030793
Disease: Pelvic Neoplasms
Pelvic Neoplasms
0.010 Biomarker group BEFREE Hypermethylated gene promoters were significantly more prevalent in renal pelvic tumors (p < 0.001), specifically for TMEFF2, GDF15, RASSF1A, SALL3 and ABCC6 (all p < 0.05). 29587736 2018
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.010 Biomarker disease BEFREE Chloroprene and valproic acid were identified as the expression regulators for genes C11orf66 and SALL3 which were captured by alcoholism SNPs, respectively. 28000566 2017
CUI: C0007847
Disease: Malignant tumor of cervix
Malignant tumor of cervix
0.010 PosttranslationalModification disease BEFREE Methylation of the SALL3 promoter was observed in 15 of 23 (65.21%) cervical cancer tissue samples, 15 of 23 (65.21%) matched pericarcinomatous tissue samples and 5 of 17 (29.41%) normal cervical tissue samples (p<0.05). 26697877 2015
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 PosttranslationalModification group BEFREE The aberrant hypermethylation of SALL3 together with HPV involvement inactivated its function as a tumor suppressor and contributed to carcinogenesis in cervical cancer. 26697877 2015
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 PosttranslationalModification disease BEFREE Methylation of the SALL3 promoter was observed in 15 of 23 (65.21%) cervical cancer tissue samples, 15 of 23 (65.21%) matched pericarcinomatous tissue samples and 5 of 17 (29.41%) normal cervical tissue samples (p<0.05). 26697877 2015